Actively Recruiting
Korean Regulatory Post Marketing Surveillance for Somavert
Led by Pfizer · Updated on 2025-07-04
100
Participants Needed
1
Research Sites
217 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Non-interventional observational study, to identify safety and effectiveness of Somavert during the post-marketing period based on the Korean RMP as required by the regulations of Ministry of Food and Drug Safety (MFDS)
CONDITIONS
Official Title
Korean Regulatory Post Marketing Surveillance for Somavert
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients prescribed Somavert according to local labeling and investigator judgment in routine practice in Korea
You will not qualify if you...
- Patients who have contraindications for Somavert
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Pfizer
Seoul, South Korea, 01037
Actively Recruiting
Research Team
P
Pfizer CT.gov Call Center
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here